162 related articles for article (PubMed ID: 36565360)
21. miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer.
Li S; Li X; Xing X; Wang L
Hum Cell; 2020 Oct; 33(4):1165-1175. PubMed ID: 32613573
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA LINC01963 inhibits progression of pancreatic carcinoma by targeting miR-641/TMEFF2.
Li K; Han H; Gu W; Cao C; Zheng P
Biomed Pharmacother; 2020 Sep; 129():110346. PubMed ID: 32559621
[TBL] [Abstract][Full Text] [Related]
23. Role of miR-489 in the proliferation and apoptosis of pancreatic carcinoma.
Zeng M; Zhou Y; Zhang Y; Wang T; Wang J
J BUON; 2019; 24(4):1574-1580. PubMed ID: 31646811
[TBL] [Abstract][Full Text] [Related]
24. circZMYM2 Competed Endogenously with miR-335-5p to Regulate JMJD2C in Pancreatic Cancer.
An Y; Cai H; Zhang Y; Liu S; Duan Y; Sun D; Chen X; He X
Cell Physiol Biochem; 2018; 51(5):2224-2236. PubMed ID: 30537731
[TBL] [Abstract][Full Text] [Related]
25. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
Zhu L; Chen Y; Nie K; Xiao Y; Yu H
Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
[TBL] [Abstract][Full Text] [Related]
27. The estrogen/miR-338-3p/ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function.
Shi Y; Pan J; Hang C; Tan L; Hu L; Yan Z; Zhu J
Environ Toxicol; 2023 Jul; 38(7):1618-1627. PubMed ID: 37052432
[TBL] [Abstract][Full Text] [Related]
28. LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Pancreatology; 2020 Sep; 20(6):1139-1148. PubMed ID: 32732173
[TBL] [Abstract][Full Text] [Related]
29. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
30. ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.
Qu G; Zhang Y; Duan H; Tang C; Yang G; Chen D; Xu Y
Apoptosis; 2023 Jun; 28(5-6):783-795. PubMed ID: 36881291
[TBL] [Abstract][Full Text] [Related]
31. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
32. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
[TBL] [Abstract][Full Text] [Related]
33. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.
Wei W; Liu Y; Lu Y; Yang B; Tang L
J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543
[TBL] [Abstract][Full Text] [Related]
34. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
An N; Zheng B
Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
[TBL] [Abstract][Full Text] [Related]
35. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
[TBL] [Abstract][Full Text] [Related]
38. Long non‑coding RNA XIST promotes cell proliferation of pancreatic cancer through miR‑137 and Notch1 pathway.
Liu PJ; Pan YH; Wang DW; You D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12161-12170. PubMed ID: 33336734
[TBL] [Abstract][Full Text] [Related]
39. Circ_0008768 Suppresses the Pancreatic Cancer Progression via miR-330- 3p/PTEN Axis.
Wang Y; Zhang J; Jia J; Qian B; Tian X
Protein Pept Lett; 2022; 29(9):796-805. PubMed ID: 35894462
[TBL] [Abstract][Full Text] [Related]
40. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
